Charles River Laboratories International Inc. has launched the Retrogenix Non-Human Protein Library, which is designed to help biopharmaceutical clients assess off-target binding to a non-human proteome to de-risk in vivo studies and aid in non-human species selection.   “Developed in-house using the innovative and unique Retrogenix platform, the new library provides early insights into how therapeutics interact with non-human protein targets in vitro,” said Aidan Synnott, Ph.D., Corporate Vic...